Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Pfeifer Thomas |

Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen

Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, N; Pfeifer, T; Rechberger, G; Lanzer, G; Kratky, D; Strunk, D BLOOD AND MARROW-DERIVED PROGENITORS ARE SUSCEPTIBLE TO MAPK P38-DEPENDENT FOAM CELL INDUCTION
HAEMATOL-HEMATOL J. 2010; 95: 1059- [Poster]
Web of Science

 

Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Rechberger, G; Kratky, D; Froehlich, E; Strunk D Pro-angiogenic induction of myeloid cells for therapeutic angiogenesis favors MAPK p38-dependent foam cell formation.
24th Meeting of the Austrian Society of Transplantation, Transfusion and Genetics2010; 42(237):13-13.-Austrotransplant; OCT 27-29, 2010; Villach, AUSTRIA. [Oral Communication]

 

Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Rechberger, G; Kratky, D; Fröhlich E; Strunk, D Pro-Angiogenic Induction of Myeloid Cells for Therapeutic Angiogenesis Can Favor MAPK p38-dependent Foam Cell Formation.
52nd annual meeting2010; 116(21):1836-1836.-Annual Society of Hematology; DEC 4-7, 2010; Orlando, USA.

 

Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Rechberger, G; Lanzer, G; Linkesch, W; Kratky, D; Strunk, D MAPK p38-dependent foam cell formation of myeloid cells after pro-angiogenic induction as a risk factor of therapeutic angiogenesis
BONE MARROW TRANSPLANT. 2010; 45: S283-S283. -36th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 21-24, 2010; Vienna, AUSTRIA. [Poster]
Web of Science

 

Buchebner, M; Pfeifer, T; Rathke, N; Chandak, PG; Kratzer, A; Haemmerle, G; Zechner, R; Cravatt, B; Kratky, D Comparison of HSL and KIAA1363: two potential cholesteryl ester hydrolases in mouse peritoneal macrophages
16 Annual meeting of the Austrian Atheroscerosis Society; May 8-9, 2009; St. Gilgen, Austria. 2009. [Oral Communication]

 

Buchebner, M; Pfeifer, T; Rathke, N; Chandak, PG; Kratzer, A; Haemmerle, G; Zechner, R; Cravatt, B; Kratky, D Comparison of HSL and KIAA1363: two potential cholesteryl ester hydrolases in mouse peritoneal macrophages
Frontier Lipidology:Lipidomics in Health and Disease; May 10-13, ; Gothenburg, Sweden. 2009. [Poster]

 

Levak-Frank, S; Obrowsky, S; Pfeifer, T; Patankar, JV; Chandak, PG; Hoefler, G; Zimmermann, R; Haemmerle, G; Zechner, R; Kratky, D Adipose triglyceride lipase plays a crucial role in intestinal triglyceride absorption
-2009; -European Lipoprotein Club; SEP 7-10, 2009; Tutzing, germany. [Oral Communication]

 

Obrowsky, S; Pfeifer T; Patankar J; Chandak PG; Zimmermann R; Zechner R; Hoefler G; Kratky D; Levak-Frank S Adipose triglyceride lipase (ATGL) plays a crucial role in intestinal triglyceride absorption
Austrian Atherosclerosis Society, Meeting 20092009; -Austrian Atherosclerosis Society, Meeting 2009; May 8-9, 2009; St. Gilgen, Austria. [Oral Communication]

 

Patankar, J; Chandak, P; Pfeifer, T; Obrowsky, S; Levak-Frank, S Intestine specific lack of GATA4 in mice decreases plasma triglyceride and cholesterol levels and promotes resistance to diet induced obesity.
Gastrointestinal Tract XIII: Advances in the Molecular and Cell Biology of the Intestinal Epithelium: Development, Inflammation, Host Defense and Cancer; AUG 7-14, 2009; Snowmass Village, Colorado, USA. 2009. [Poster]

 

Patankar, J; Chandak, P; Pfeifer, T; Obrowsky, S; Levak-Frank, S Intestinal knockout of GATA4 decreases plasma triglyceride and cholesterol levels and is resistant to weight gain.
Austrian Atherosclerosis Society Annual Conference 2009; MAY 8-9, 2009; St. Giligen, Austria. 2009. [Oral Communication]

 

Rohde, E; Pfeifer, T; Schallmoser, K; Reinisch, A; Hofmann, NA; Froehlich, E; Rechberger, G; Lanzer, G; Kratky, D; Strunk, D Pro-atherogenic risk of cellular therapy for vascular regeneration?
BONE MARROW TRANSPLANT. 35th Annual Meeting of the European Group for Blood and Marrow Transplantation2009; 43(1):S203-S204.-35th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 29-APR 01, 2009; Goteborg, SWEDEN. [Poster]
Web of Science

 

Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Froehlich, E; Rechberger, G; Lanzer, G; Kratky, D; Linkesch, W; Strunk, D CELLULAR THERAPEUTIC ANGIOGENESIS: IN VITRO FOAM CELL DEVELOPMENT OF MONOCYTES BUT NOT MESENCHYMAL STROMAL CELLS.
3rd International Workshop on Multipotent Stromal Cells (MSCs) for Regenerative Medicine and Immune Regulation; JUN 12-13, 2009; Frankfurt am Main, GERMANY. 2009. [Poster]

 

Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Froehlich, E; Rechberger, G; Lanzer, G; Kratky, D; Linkesch, W; Strunk, D In vitro Foam Cell Development of Bone Marrow-Derived Cells: Implications for Therapeutic Angiogenesis?
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie2009; 32(4):215-216.-Deutsches Gesellschaft für Hämatologie und Onkologie; OCT 2-6, 2009; Heidelberg / Mannheim, GERMANY. (ISBN: 978-3-8055-9351-9 ) [Oral Communication]

 

Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Froehlich, E; Rechberger, G; Lanzer, G; Kratky, D; Linkesch, W; Strunk, D Increased Foam Cell Potential of Human Blood and Marrow-Derived Cells after Pro-Angiogenic Induction as an Apparent Risk Factor of Therapeutic Angiogenesis.
42nd Annual Meeting of the German Society for Transfusion Medicine and Immunohematology2009; 26(S1):45-45.-German Society for Transfusion Medicine and Immunohematology (DGTI); SEP 15-18, 2009; Rostock, GERMANY. (ISBN: 978-3-8055-9325-0 ) [Poster]

 

Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Froehlich, E; Rechberger, G; Lanzer, G; Kratky, D; Linkesch, W; Strunk D Foam Cell Development of human Blood and Marrow-Derived Cells as a Risk Factor of Therapeutic Angiogenesis?
ZMF-Doctoral Day; NOV 5-6, 2009; Graz, AUSTRIA. 2009. [Poster]

 

Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Froehlich, E; Rechberger, G; Lanzer, G; Kratky, D; Linkesch, W; Strunk D Safety of stem cell transplantation to treat cardiovascular diseases: foam cell formation of human blood and marrow-derived cells as a risk factor of therapeutic angiogenesis?
23rd Meeting of the Austrian Society of Transplantation, Transfusion and Genetics2009; 41(231):10-11.-23rd Meeting of the Austrian Society of Transplantation, Transfusion and Genetics; OCT 21-23, 2009; Seefeld, AUSTRIA. [Oral Communication]

 

Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA.; Pfeifer, T; Fröhlich, E; Rechberger, G; Lanzer, G; Kratky, D; Linkesch, W; Strunk, D Elevated Foam Cell Formation After Pro-Angiogenic Inductions of Human Blood and Marrow-Derived Cells as an Apparent Risk Factor of Therapeutic Angiogenesis.
International Society for Stem Cell Research 7th Annual Meeting; JUL 8-11, 2009; Barcelona, SPAIN. 2009. [Poster]

 

Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Fröhlich, E; Rechberger, G; Lanzer, G; Kratky, D; Linkesch, W; Strunk, D Atherogenesis as a risk factor accompanying cellular therapeutic angiogenisis?
2009 Proceedings of the Annual Meeting of the Austrian Society of Haematology and Oncology2009; 2(2):19-20.-ÖGHO Frühjahrestagung; APR 16-18, 2009; Salzburg, AUSTRIA. (ISBN: 1865-5041 ) [Poster]

 

Wolf, H; Tomazic, PV; Pfeifer, T; Lang-Loidolt, D; Schmut, O Gleicher Effekt von Pollenproteasen auf Nasensekret und Tränenflüssigkeit bei Pollenallergikern und Gesunden
Spektrum der Augenheilkunde Zeitschrift der Österreichischen Ophthalmologischen Gesellschaft2009; 23(2):59-167.-50. Tagung der Österreichischen Ophthalmologischen Gesellschaft; MAI 21-23, 2009; Bad Ischl, AUSTRIA. [Poster]

 

Buchebner, M; A. Kratzer, T.M. Becker, B. Ebner, N. Rathke, T. Pfeifer, S. Levak-Frank, G.M. Kostner and D. Kratky Synthetic LXR agonist attenuates plaque formation and reduces plasma triglycerides in apoE-deficient mice without inducing liver steatosis
15. Austrian Ateriosclerosis Society Annual Meeting; 18. – 19. April 2008; St.Gilgen, Austria. 2008. [Oral Communication]

 

Buchebner, M; A. Kratzer, T.M. Becker, B. Ebner, N. Rathke, T. Pfeifer, S. Levak-Frank, G.M. Kostner and D. Kratky Synthetic LXR agonist attenuates plaque formation and reduces plasma triglycerides in apoE-deficient mice without inducing liver steatosis
2nd International Graz Symposium on Lipid and Membrane Biology: Focus on Lipotoxicity ; March 13-15; Graz, Austria. 2008. [Poster]

 

Buchebner, M; A. Kratzer, T.M. Becker, B. Ebner, N. Rathke, T. Pfeifer, S. Levak-Frank, G.M. Kostner and D. Kratky Synthetic LXR agonist attenuates plaque formation and reduces plasma triglycerides in apoE-deficient mice without inducing liver steatosis
14th ANNUAL SCANDINAVIAN ATHEROSCLEROSIS CONFERENCE; June 11-14, 2008; Humlebaek, Denmark. 2008. [Oral Communication]

 

Hasslitzer, K; Becker, T; Schweinzer, C; Stefulj, J; Pfeifer, T; Sattler, W and Panzenboeck, U Characterization of phospholipid transfer protein in the brain and at the blood brain barrier
Joint Meeting Life Sciences 2008; September 22nd -24th, 2008 ; Graz, Austria. 2008. [Poster]

 

Kratzer, A; Buchebner, M; Becker, TM; Pfeifer, T; Uray, G; Ebner, B; Rathke, N; Ahammer, H; Trauner, M; Hoefler, G; Levak-Frank, S; Levi, M; Kostner, GM; Kratky, D Partial LXR agonist reduces atherosclerosis in ApoE-deficient mice without inducing liver steatosis and hypertriglyceridemia
Experimental Biology 2008 (ASBMB); April 5-9, 2008; San Diego, USA. 2008. [Poster]

 

Kratzer, A; Buchebner M, Pfeifer T, Becker TM, Uray G, Miyazaki M, Miyazaki-Anzai S, Ebner B, Chandak PG, Kadam RS, Calayir E, Rathke N, Ahammer H, Radovic B, Trauner M, Hoefler G, Kompella UB, Fauler G, Levi M, Levak-Frank S, Kostner GM, Kratky D Synthetic LXR agonist reduces atherosclerotic plaque formation in ApoE deficient mice without inducing liver steatosis and hypertriglyceridemia
OEGBM meeting 22th to 24th September 2008, Graz, Austria; SEPT 22-24, 2008; Graz, AUSTRIA. 2008. [Oral Communication]

 

Kratzer, B; Ebner, T. Becker, E. Calayir, C. Guelly, M. Buchebner, T. Pfeifer, N. Rathke, S. Levak-Frank, N. Barry, T. Jiang, X. Wang, N. Zelcer, P. Tontonoz, M. Levi, G.M. Kostner, D. Kratky Novel Effects of Liver X Receptor (LXR) agonist N,N-Dimethyl-3â-hydroxycholenic acid (DMHCA) on the gene regulation and morphology of mouse peritoneal macrophages
Keystone symposium on nuclear receptors: orphan brothers and steroid sisters ; APRIL 30-May 4, 2008 ; Whistler, Canada. 2008. [Poster]

 

Pfeifer, T; Buchebner,M; Chandak,GP; Patankar,J; Kratzer,A; Obrowsky,S; Rechberger,G; Kostner,GM; Kratky,D; Levak-Frank, S; New synthetic oxysterol ligand of LXR significantly reduce the intestinal cholesterol absorption in vitro and in vivo
Austrian Atherosclerosis Society, Meeting 2008; APR 18-19, 2008; St.Gilden Austria. 2008. [Oral Communication]
FullText

 

Pfeifer, T; Kratzer, A; Buchebner, M; Chandak, PG; Patankar, J; Obrowsky, S; Kostner, GM; Kratky, D and Levak-Frank, S Synthetic LXR agonist reduces the intestinal cholesterol absorption in wild-type mice and attenuates plaque formation in apoE-deficient mice.
Cellular Lipid Transport - Connecting Fundamental Membrane Assembly The American Society for Biochemistry and Molecular Biology Annula Meeting ; October 22-26, 2008 ; Canmore, Alberta, Canada. 2008. [Poster]

 

Becker, TM; Pfeifer, T; Buchebner, M; Ebner, B; Kratzer, A; Kostner, GM; Kratky, D Identification of lipolytic enzymes and their potential roles in cellular cholesterol homeostasis
13th ANNUAL SCANDINAVIAN ATHEROSCLEROSIS CONFERENCE ; March 28-31, 2007 ; Humlebaek, Danmark. 2007. [Oral Communication]

 

Becker, TM; Pfeifer, T; Kratzer, A; Ebner, B; Buchebner, M; Birner-Grünberger, R; Hermetter, A; Malli, R; Kostner, GM; Kratky, D; Characterization of in silico identified cholesteryl ester hydrolases in liver and macrophages
Gold Workshop 2007; MRZ 23-24.03.2007; Seggau, Austria. 2007. [Poster]
FullText

 

Ebner, B; Becker, T; Kratzer, A; Calayir, E; Buchebner, M; Trajanoski, Z; Gülly, C; Levak-Frank, S; Kostner; GM; Kratky, D Further characterization of MIG12, a novel gene involved in sterol and lipid metabolism
Gold Workshop 2007; 23-24.03.2007; Seggau, Austria. 2007. [Poster]

 

Effects of a Novel Liver X Receptor (LXR) Agonist on Murine Cholesterol and Lipid Metabolism Kratzer,A; Ebner,B; Becker,TM; Pfeifer,T; Calayir,E; Buchebner,M; Uray,G; Rechberger,G; Sattler,W; Lackner,K; Gülly,C; Levak-Frank,S; Kostner,GM and Kratky,D Effects of a Novel Liver X Receptor (LXR) Agonist on Murine Cholesterol and Lipid Metabolism
GOLD II meeting; MARCH 2007; SEGGAU. 2007. [Poster]

 

Kratzer, A; Ebner, B; Becker, TM; Pfeifer, T; Calayir, E; Buchebner, M; Uray, G; Rechberger, G; Sattler, W; Guelly, C; Levak-Frank, S; Kostner, GM; and Kratky, D Influences of a novel liver X receptor (LXR) agonist on cholesterol an lipid metabolism in murine macrophages and liver
Kern Aspen Lipid Conference; AUGUST 18-21, 2007; Aspen, CO, USA. 2007. [Poster]

 

Pfeifer, T; Becker, TM; Levak-Frank, S;Malli, R; Kratzer,A; Ebner,B; Kostner,GM; Kratky, D Localization of potential cholesteryl ester hydrolases (pCEH) in macrophages and liver cells.
14. Jahrestagung der Österreichischen Atherosklerosegesellschaft – AustrianAtherosclerosis Society (AAS); May 11-12, 2007; St.Gilden, Austria. 2007. [Oral Communication]

 

Pfeifer, T;Becker,TM; Levak-Frank,S; Frank,S; Malli, R; Kratzer, A; Calayir, E; Ebner, B; Ibovnik, A; Kostner, GM and Kratky, D; Localization of potential cholesteryl ester hydrolases (pCEH) in macrophages and liver cells
13rd ANNUAL SCANDINAVIAN ATHEROSCLEROSIS CONFERENCE; MRZ 28-31.03.2007; Humlebæk, Denmark. 2007. [Poster]
FullText

 

Pfeifer, T;Becker,TM; Levak-Frank,S; Frank,S; Malli, R; Kratzer, A; Calayir, E; Ebner, B; Ibovnik, A; Kostner, GM and Kratky, D; Klonierung und zelluläre Lokalisation von neuen Hydrolasen
-Jahrestagung Arbeitskreis Klinischer Lipidstoffwechsel, ; Maikammer, Germany . [Oral Communication]

 

Pfeifer, J Medizin und Entwicklungshilfe.
Hygieneinstitut; JAN 28, 2005; Graz, AUSTRIA. 2005. [Oral Communication]

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum